Sympathetic Vasoconstriction During Exercise in Ambulatory Patients
In patients with heart failure, exercise is thought to increase sympathetic vasoconstrictor tone.
To investigate the extent of this sympathetic activation, we studied the effect of maximal exercise on nonexercising vascular beds in 35 patients with left ventricular failure (ejection fraction, 21±8%; peak exercise oxygen uptake (V02), 12.3-±3.5 ml/min/kg). In 28 patients, cardiac output and leg blood flow were measured during maximal upright bicycle exercise. Total flow to nonexercising tissue was then calculated as cardiac output-(2xleg flow). In seven patients and six normal subjects, forearm blood flow was measured during supine bicycle exercise before and after a'adrenergic blockade with intravenous phentolamine. Maximal upright exercise increased the vascular resistance of nonexercising tissue from 34±16 units at upright rest to 45+±25 units (p<0.02) but did not affect total flow to nonexercising tissue (rest, 2.9±-1.0; maximal exercise, 2.8±1.4 1/mmi; p=NS). Supine exercise had no significant eifect on forearm blood flow or vascular resistance in the normal subjects. In the patients with heart failure, supine exercise increased forearm vascular resistance from 45±+17 to 58±25 mm Hg/ ml/min/100 ml (p<0.02), again with no change in tissue flow (rest, 2.4±0.1; maximal exercise, 2.4+±0.9 ml/min/100 ml; p=NS). The increase in forearm vascular resistance was associated with only a modest increase in plasma norepinephrine levels (rest, 258±129; maximal exercise, 635± 188 pg/ml) and was unalfected by prior administration of phentolamine. These findings suggest that exercise does not produce a major increase in sympathetic vasoconstrictor tone in ambulatory patients with left ventricular failure. (Circulation 1989 ;79:1021-1027) D uring exercise, patients with left ventricular failure frequently exhibit greater-thannormal increases in plasma norepinephrine levels.1"2 It is generally believed that this rise reflects augmented sympathetic vasoconstrictor tone,1,2 which shunts blood away from nonexercising portions of the circulation to working skeletal muscle. [3] [4] [5] [6] [7] [8] [9] In patients with severe exercise intolerance, it has been further speculated that the level of sympathetic vasoconstrictor activity may be sufficiently intense to impair arteriolar vasodilation in working skeletal muscle and thereby contribute to muscle underperfusion.5
There is a growing body of recent evidence, however, that raises the possibility that exercise produces considerably less sympathetic vasoconstriction than previously thought. Francis et al10 have pointed out that, relative to the strenuousness of exercise, plasma norepinephrine levels in patients with left ventricular failure are actually lower than in normal subjects. A number of investigators have observed that sympathetic reflex control of peripheral resistance vessels appears to be impaired by left ventricular failure. For example, attenuated forearm vasoconstrictor responses to orthostatic tilt and lower body negative pressure have been noted in patients with left ventricular failure. have observed attenuated hindlimb vasoconstrictor response to lumbar chain stimulation in experimental heart failure.'5 Others have demonstrated that elevated resting plasma norepinephrine levels in heart failure to a substantial extent reflect impaired norepinephrine uptake and therefore overestimate sympathetic vasoconstrictor activity. '6"17 The present study was undertaken to investigate the degree to which exercise produces sympatheti-cally mediated vasoconstriction in ambulatory patients with left ventricular failure. To this end, we examined the effect of maximal bicycle exercise on nonexercising vascular beds. We reasoned that if intense sympathetic vasoconstriction occurs during exercise, this vasoconstriction should reduce flow to nonexercising tissue. To assess nonexercising vascular bed flow and resistance, we measured leg blood flow and cardiac output responses to upright bicycle exercise. By subtracting leg blood flow from cardiac output, we were able to obtain an estimate of blood flow to nonexercising tissue. In a separate group of patients, we measured forearm blood flow and resistance during maximal supine leg exercise. Forearm measurements were repeated after aadrenergic blockade with phentolamine to elucidate the extent to which vasoconstrictor effects were due to sympathetic activation.
Methods

Patient Population
Thirty-five patients with a mean age of 57±10 years and an average left ventricular ejection fraction of 21±8% were studied. Left ventricular dysfunction was attributed to coronary artery disease in 18 patients, to an idiopathic cardiomyopathy in 12, and to a hypertensive cardiomyopathy in five. All patients had a reduced maximal exercise capacity (peak exercise oxygen uptake [V02] <20 ml/min/kg), with an average peak exercise VO2 of 12.3±3.5 ml/ min/kg. All patients were also receiving chronic therapy with digoxin. However, to avoid digitalis-induced vasoconstriction and changes in baroreceptor behavior,138-20 digoxin was discontinued 7 days prior to studies in all seven patients who underwent forearm blood flow studies. Vasodilator therapy was discontinued at least 3 days prior to studies. Forearm studies were also perforrned in six normal male subjects with a mean age of 53±5 years. The protocol was approved by the Institutional Research Committee of the University of Pennsylvania, and written consent for the protocol was obtained from all subjects.
Upright Exercise Protocol
On the day before study, a trial maximal exercise test was performed to acquaint the patient with the exercise protocol. Exercise was performed on an upright bicycle ergometer (Monarch, Varberg, Sweden), beginning at a work load of 20 W. Every 3 minutes the work load was increased by 20 W to symptomatic maximum. All exercise tests were performed at least 4 hours after meals.
The following morning a Swan-Ganz catheter was inserted through an antecubital vein and positioned in the pulmonary artery. A short polyethylene catheter was inserted into a radial artery. A 5F thermodilution catheter was inserted percutaneously into the left femoral vein and advanced 15-16 cm anterograde into the iliac vein to measure leg blood flow, as previously described. 21, 22 Thirty minutes after instrumentation, hemodynamic measurements were made and blood samples were obtained from the radial artery, femoral vein, and pulmonary artery for determination of 02 saturation. Femoral venous blood flow was measured in triplicate. After rapid injection of a 2.5 -ml iced dextrose bolus, flow was determined by a commercially available thermodilution computer (Elecath, Rahway, New Jersey). Output curves were displayed on a strip-chart recorder to ensure an exponential decay curve. Respiratory gases were measured with a Beckman Metabolic Cart equipped with 02 and CO2 analyzers and a turbine volume transducer. The patient then mounted the bicycle and was allowed to equilibrate for 5 minutes, after which all measurements were repeated.
Respiratory gas measurements were made continuously while the patient exercised. Blood sampling and hemodynamic measurements were repeated at the end of each exercise stage and at peak exercise.
Hemoglobin concentration was measured by Coulter counter, and hemoglobin 02 saturation was measured with a co-oximeter (Instrumentation Laboratories, Lexington, Massachusetts) precalibrated with human blood. Blood 02 content was calculated as the product of hemoglobin, 1.34 ml O2/g hemoglobin, and percent 02 saturation. Cardiac output was calculated from the Fick principle as VO] arteriovenous 02 difference. Non-leg blood flow was calculated as cardiac output-(2xleg flow). Non-leg vascular resistance was calculated as (mean arterial blood pressure)/(non-leg blood flow). Supine Exercise Protocol Seven patients with heart failure and six normal subjects were studied. All subjects had performed at least one trial bicycle exercise test before studies. On the day of study, the subject came to the laboratory in a fasting state. Temperature in the laboratory was maintained at 70°F. With the subject lying supine on a bed, a right antecubital vein intravenous line was inserted. A mercury-in-Silastic strain gauge was placed around the left forearm approximately 5 cm below the antecubital crease and connected to a plethysmograph (Parks Electronics Laboratory, Beaverton, Oregon). A cuff was placed around the upper arm and connected to a pneumatically powered rapid cuff inflator (D.E. Hokanson, Inc, Issaquah, Washington). A second cuff was placed around the wrist and inflated to suprasystolic pressure at least 1 minute before forearm blood flow measurements. The left arm was elevated 10 cm above the anterior chest with a sling arrangement to ensure that there was no obstruction to venous return and to minimize forearm motion during exercise.
Thirty minutes after instrumentation, five to 10 forearm flow measurements were made at rest. Flow was determined by rapidly inflating the upper arm cuff to 60 mm Hg and observing the rate of increase in forearm circumference. Flow was Following completion of the exercise protocol, the subject was allowed to rest for 2 hours. The entire exercise protocol was then repeated.
At rest and at each work load, blood pressure was measured in the right arm with a sphygmomanometer. During one of the two exercise protocols in the randomized sequence, exercise was immediately preceded by administration of a phentolamine bolus (5 mg i.v.) with a subsequent continuous infusion of phentolamine. The infusion rate was 0.4 mg/min in the first four patients and all normal subjects. In the remaining three patients, the rate was increased to 1 mg/min to ensure that a higher infusion rate would not produce more blockade of forearm vasoconstrictor responses than did the lower infusion rate. No difference in forearm vascular responses to exercise were observed in patients with the lower versus the higher infusion rates. During the exercise protocol without phentolamine, blood samples were obtained from the antecubital vein at rest and during each level of exercise for determination of plasma norepinephrine levels23 and plasma renin activity.24 Samples were immediately spun in a refrigerated centrifuge and analyzed later for norepinephrine with a radioenzymatic assay (CAT-A-KIT, Amersham, Arlington Heights, Illinois) and for renin with a radioimmunoassay kit (GammaCoat Kit, Dade-Baxter Travenol Diagnostics, Cambridge, Massachusetts).
Mean arterial blood pressure was calculated as the diastolic pressure plus one third of the pulse pressure. Forearm vascular resistance was calcu-lated by dividing mean arterial blood pressure by forearm blood flow.
To ensure that intravenous phentolamine produced forearm sympathetic blockade, forearm blood flow and resistance were measured in two normal subjects before and while they immersed a hand in ice water for 1/2 minutes. The cold pressor test was then repeated after infusion of a 5-mg bolus of phentolamine followed by a continuous infusion of 0.4 mg/min. In the first subject, the cold pressor test increased forearm vascular resistance from 25.7 to 68.5 mm Hg/ml/min/100 ml before phentolamine but to only 27.3 mm Hg/ml/min/100 ml during phentolamine infusion. In the other subject, forearm resistance increased from 42.7 to 81.0 mm Hg/ml/min/ 100 ml before phentolamine but to only 43.7 mm Hg/ ml/min/100 ml during phentolamine infusion.
Statistical Analysis
All data are expressed as mean+ SD. Comparison of exercise values with rest values was performed with paired Student's t test. Ap value of <0.05 was considered statistically significant.
Results
Upright Bicycle Exercise
As shown in Table 1 , at supine rest, V02 averaged 249±39 ml/min, cardiac output 3.7+1.1 1/min, pulmonary wedge pressure 23+8 mm Hg, and leg blood flow 0.3±0.1 1/min. Exercise increased V02 to 850±307 ml/min, cardiac output to 6.8±2.5 l/ min, pulmonary wedge pressure to 31±9 mm Hg, and leg blood flow to 2.0+1.0 1/min. At upright rest, non-leg blood flow was 2.9± 1.01/ min, whereas non-leg vascular resistance averaged 34±16 units. With exercise, non-leg vascular resistance increased approximately 45% above resting levels to 45±25 units, indicating vasoconstriction. However, mean arterial blood pressure also increased, from 86±10 to 98±14 mm Hg, counterbalancing the increase in vascular resistance so that non-leg blood flow at maximal exercise, 2.8±1.4 l/ min, remained unchanged from resting levels. (Table 3 ). 3.0+0.7 ml/min/100 ml), forearm vascular resis-Without a-adrenergic blockade, resting mean artetance (rest, 43+22; 400-kpm work load, 41+13 rial pressure was 96±11 mm Hg, forearm blood mm Hg/ml/min/100 ml), or plasma renin activity. flow 2.4±1.0 ml/min/100 ml, and forearm vascular Plasma norepinephrine levels increased signifi-resistance 44.6±16.6 mm Hg/ml/min/100 ml. Plasma cantly at the 400 -kpm work load (from 181 ± 125 pg/ norepinephrine averaged 258±129 pg/ml and renin ml at rest to 749±375 pg/ml, p<0.03). activity 2.8±1.7 pg/ml. These values were not signif-Phentolamine administration decreased arterial icantly dilferent from values in the normal subjects. blood pressure both at rest and throughout exer-Exercise was associated with higher heart rates in cise. Compared with control exercise, forearm blood patients with heart failure than in control subjects flow tended to be higher at rest and during exercise, but blood pressures were comparable. Forearm but this difference did not reach statistical signifiblood flow increased slightly at the 200-kpm work cance. However, exercise again had no effect on load but subsequently was unchanged from resting blood flow. Forearm vascular resistance increased levels. In contrast to that in the control subjects, forearm vascular resistance in patients increased significantly during exercise to a level of 58+±25 mm Hg/ml/min/100 ml, or approximately 30% above resting levels. This change in forearm vascular resistance was associated with plasma norepinephrine levels not significantly greater than those in the control subjects. However, plasma renin activity in the patients with heart failure was markedly higher during exercise, reaching at peak exercise 44.5 + 13.3 pg/ml/hr versus only 1.0±+0.8 pg/ml/hr in the control subjects.
Phentolamine significantly decreased arterial blood pressure at rest but did not change it during exercise. Exercise again increased the forearm vascular resistance from 39+13 at rest to 48+16 mm Hg/ml/ min/100 ml (p<0.04) at peak exercise but without change in forearm blood flow.
There was no significant difference between forearm vascular resistance and flow measurements made before and those made after phentolamine administration.
Discussion
In normal subjects, strenuous exercise is associated with a generalized increase in sympathetic vasoconstrictor activity and angiotensin Il.25,26 These neurohumoral responses serve to increase vascular resistance in nonworking tissues and thereby augment the arterial blood pressure and redistribute blood from nonworking tissues to exercising muscle.27 In working skeletal muscle, local metabolic factors override these neurohumoral influences and produce vasodilation.
It has been postulated that this normal pattern of responses is accentuated in patients with left ventricular failure, possibly to a deleterious extent. According to this hypothesis, sympathetic activation is substantially elevated above normal at low work levels, producing both intense vasoconstriction and flow reductions in nonworking tissues.4-9 It has been further suggested that the degree of vasoconstriction may be sufficiently intense to override local metabolic factors in working skeletal muscle and thereby interfere with muscle flow. 5 Results of the present study confirm that vasoconstriction occurs in nonexercising vascular beds during maximal exercise in patients with heart failure. However, several observations suggest that the degree of sympathetic vasoconstriction produced by exercise is considerably less than previously thought. First, the observed vasoconstriction had no significant affect on blood flow to nonexercising tissues. Second, the forearm vasoconstriction noted during supine exercise was associated with abnormal increases in plasma renin activity rather than in plasma norepinephrine levels, suggesting that this vasoconstriction may be caused by production of angiotensin II rather than by heightened sympathetic tone. Third, the forearm vasoconstriction was not blocked by phentolamine, further implicating a mechanism other than heightened sympathetic tone.
Blood Flow to Nonexercising Tissues
During exercise, the main regions which can redistribute significant quantities of blood to working muscle are the splanchnic beds, the renal vascular beds, and nonexercising skeletal muscle. In normal man, maximal exercise reduces blood flow to these areas by 50-80%. 27 This flow reduction is associated with plasma norepinephrine levels in excess of 2,000 pg/ml, leading to the general presumption that the flow change is due to a marked elevation in sympathetic vasoconstrictor activity.
In the present study, maximal bicycle exercise produced a significant increase in both forearm and total non-leg vascular resistance of our patients, indicating substantial vasoconstriction in nonexercising tissue. However, because this vasoconstriction was accompanied by a concurrent rise in arterial blood pressure, blood flow to nonexercising tissues remained unchanged. No change was noted in either forearm flow or vascular resistance in the normal subjects, a finding consistent with prior observations in normal subjects performing mild exercise. 28, 29 Results of the present study therefore suggest that, in contrast to normal subjects performing maximal exercise, patients with heart failure do not develop major redistributions of blood flow from nonexercising beds to exercising muscle. Although vasoconstriction occurs, this effect is counterbalanced by an increase in blood pressure. Thus, in contrast to the widely held view that patients with heart failure exhibit during exercise intense vasoconstriction that reduces flow to nonexercising beds, our results suggest that the degree of vasoconstriction may in fact be substantially less than that in normal subjects exercising maximally.
Our finding that non-leg and forearm blood flow do not decrease during exercise in patients with left ventricular failure contrasts with findings in patients with heart failure caused by rheumatic valvular disease. In the latter group, prior observations indicate that exercise-induced flow redistribution occurs. Specifically, exercise in such patients has been demonstrated to decrease forearm blood flow4; forearm, renal, and hepatic venous 02 saturation6-8; and hepatic clearance of indocyanine green.9
There are several potential explanations for the differences between results of the present study and findings in patients with rheumatic heart disease. The patients in the present study were ambulatory and may not have been as hemodynamically compromised as patients with rheumatic valvular disease. The different responses may be due to differences in the underlying cardiac disease; most of the patients with rheumatic valvular disease had mitral stenosis. In addition, we discontinued digoxin in our patients prior to forearm studies. In previous studies, digitalis preparations were continued and may have augmented sympathetic vasoconstrictor responses to exercise by increasing baroreceptor sensitivity.13,18 Furthermore, digitalis is known to be a direct vasoconstrictor19 and to increase the vasoconstrictor effects of angiotensin II and norepinephrine,20 properties that would also tend to augment exercise-induced vasoconstriction.
It should be noted that our findings do not exclude the possibility that some blood flow redistribution occurred within nonexercising tissues in our patients. For example, splanchnic blood flow could have decreased while cardiac and thoracic wall muscle flow could have increased, resulting in no overall change in flow.
Contribution of Sympathetic Activation to Exercise Vasoconstriction
To investigate the contribution of sympathetic activity to the exercise-induced forearm vasoconstriction noted in our patients, plasma norepinephrine levels were obtained during exercise, and forearm vascular responses were reexamined after aadrenergic blockade with phentolamine. At rest, plasma norepinephrine levels tended to be higher in the patients with heart failure, although not to a significant extent. During exercise, plasma norepinephrine levels increased over twofold in all patients, consistent with an increase in sympathetic activity. Although the levels again tended to be higher than in the normal subjects, this trend was not significant, suggesting that sympathetic activation did not produce the forearm vasoconstriction. Further supporting this conclusion, the forearm vasoconstriction was not blocked by phentolamine administration.
Kirlin et a130 also noted comparable norepinephrine levels in normal subjects and in ambulatory patients with heart failure both at rest and during exercise. In contrast, Chidsey et all and Francis et a12 demonstrated higher-than-normal norepinephrine levels in patients with heart failure. This apparent discrepancy between the results of different studies is probably related to differences in study populations. Both in the present study and in the study of The exact mechanism by which exercise increased forearm vascular resistance in our patients cannot be determined from the present study. We cannot exclude a role for sympathetic activation because phentolamine does not totally block a-receptors. Interestingly, the increase in plasma renin activity noted during exercise was much greater in the patients than in the normal subjects. Kirlin et a130 observed a similar pattern in their study. This increase in renin activity may have produced sufficient angiotensin II to augment forearm vascular resistance. Local autoregulation of forearm blood flow also could contribute to the increase in forearm resistance.
Modulation of Sympathetic Activity in Heart Failure
Results of this study suggest that ambulatory patients with left ventricular failure develop relatively little sympathetic vasoconstrictor activity during bicycle exercise. This conclusion is consistent with a growing number of observations which suggest that sympathetic vasoconstrictor effects are considerably less pronounced in left ventricular failure than previously thought. Attenuated forearm vasoconstrictor responses to orthostatic tilt and lower body negative pressure have been noted in such patients, suggesting impaired sympathetic reflex control of peripheral resistance vessels. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] We have recently noted that hindlimb vascular responses to lumbar sympathetic chain stimulation are impaired by experimental heart failure. 15 Other observations suggest that heart failure may impair sympathetic neurotransmitter production and/or release. [33] [34] [35] [36] Clinical Implications
The apparent failure of sympathetic vasoconstrictor tone to increase more markedly in our patients has important clinical implications. Previous therapeutic interventions designed to influence sympathoadrenal activity in heart failure have focused exclusively on blocking this activity. Results of the present study suggest that such an approach may have little or no long-term benefit in ambulatory patients with moderate exercise intolerance, a conclusion supported by the failure of chronic a-adrenergic blocking agents to improve the clinical status of such patients.37,38 One might even argue that an intervention designed to enhance sympathetic activity might be beneficial in increasing cardiac inotropy and shunting blood from nonexercising tissues to working skeletal muscle. However, such an approach might also increase cardiac afterload, reduce cardiac output, and impair muscle perfusion. Enhancing sympathetic activity, therefore, may not improve skeletal muscle performance. In support of this conclusion, Maskin et a139 observed no acute beneficial effect of dopamine infusion on the exercise capacity of patients with heart failure.
